ARTICLE | Company News
Alnylam said Sanofi’s Sanofi Genzyme unit declined to exercise an option to co-develop and co-commercialize ALN-CC5 in territories outside of the U.S., Canada and Western Europe under a 2014 deal to d...
Alnylam said Sanofi’s Sanofi Genzyme unit declined to exercise an option to co-develop and co-commercialize ALN-CC5 in territories outside of the U.S., Canada and Western Europe under a 2014 deal to d...